|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.1 CNY | -0.33% |
|
+0.33% | -17.65% |
| 05-14 | Zhejiang Jianfeng's Pharmaceutical Unit Gets Nod to Market Anti-Tumor Drug | MT |
| 05-07 | Jianfeng Group's Pharma Unit Gets Nod to Sell Glaucoma Eye Drops | MT |
Zhejiang Jianfeng Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 601.67 million compared to CNY 607.34 million a year ago. Net income was CNY 2.43 million compared to CNY 23.15 million a year ago.
Basic earnings per share from continuing operations was CNY 0.0071 compared to CNY 0.07 a year ago. Diluted earnings per share from continuing operations was CNY 0.0071 compared to CNY 0.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.65% | 434M | |
| +20.24% | 48.59B | |
| +8.09% | 16.48B | |
| -3.26% | 15.81B | |
| -9.89% | 11.24B | |
| +35.33% | 9.26B | |
| -4.45% | 7.76B | |
| +43.06% | 7.76B | |
| -5.09% | 7.58B | |
| +105.28% | 7.34B |
ZHEJIANG JIANFENG GROUP CO., LTD. 
